We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA and Centers for Medicare & Medicaid Services have approved the first product ever under the two agencies’ joint pilot program for parallel review – Exact Sciences’ Cologuard, a noninvasive screening test for colorectal cancer. Read More
The FDA roundly rejected a citizen’s petition from the Minnesota Medical Device Alliance that had sought multiple changes to the 510(k) notification process. Read More